207 related articles for article (PubMed ID: 32615321)
1. Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.
Lakshmanan S; Shekar C; Kinninger A; Dahal S; Onuegbu A; Cai AN; Hamal S; Birudaraju D; Cherukuri L; Flores F; Dailing C; Roy SK; Bhatt DL; Nelson JR; Budoff MJ
Atherosclerosis; 2020 Jul; 305():34-41. PubMed ID: 32615321
[TBL] [Abstract][Full Text] [Related]
2. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
4. Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio.
Manubolu VS; Verghese D; Lakshmanan S; Alalawi L; Kinninger A; Bitar JA; Calicchio F; Ahmad K; Ghanem A; Javier DA; Mangaoang C; Flores F; Dailing C; Roy SK; Budoff MJ
J Clin Lipidol; 2022; 16(5):715-724. PubMed ID: 35778256
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
6. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
9. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
10. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Budoff MJ; Bhatt DL; Kinninger A; Lakshmanan S; Muhlestein JB; Le VT; May HT; Shaikh K; Shekar C; Roy SK; Tayek J; Nelson JR
Eur Heart J; 2020 Oct; 41(40):3925-3932. PubMed ID: 32860032
[TBL] [Abstract][Full Text] [Related]
11. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
[TBL] [Abstract][Full Text] [Related]
12. Improvement in LDL is associated with decrease in non-calcified plaque volume on coronary CTA as measured by automated quantitative software.
Tamarappoo B; Otaki Y; Doris M; Arnson Y; Gransar H; Hayes S; Friedman J; Thomson L; Wang F; Rozanski A; Slomka P; Dey D; Berman D
J Cardiovasc Comput Tomogr; 2018; 12(5):385-390. PubMed ID: 29793847
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography.
Cheng VY; Wolak A; Gutstein A; Gransar H; Wong ND; Dey D; Thomson LE; Hayes SW; Friedman JD; Slomka PJ; Berman DS
Am J Cardiol; 2010 Mar; 105(6):761-6. PubMed ID: 20211316
[TBL] [Abstract][Full Text] [Related]
14. Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and body mass index with coronary plaque regression.
Tani S; Matsumoto M; Nakamura Y; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2012 Aug; 12(4):279-86. PubMed ID: 22747341
[TBL] [Abstract][Full Text] [Related]
15. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
[TBL] [Abstract][Full Text] [Related]
16. Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
[TBL] [Abstract][Full Text] [Related]
17. Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
Stegman B; Shao M; Nicholls SJ; Elshazly M; Cho L; King P; Kapadia S; Tuzcu M; Nissen SE; Puri R
Atherosclerosis; 2016 Nov; 254():78-84. PubMed ID: 27710808
[TBL] [Abstract][Full Text] [Related]
18. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study.
Zeb I; Li D; Nasir K; Malpeso J; Batool A; Flores F; Dailing C; Karlsberg RP; Budoff M
Atherosclerosis; 2013 Dec; 231(2):198-204. PubMed ID: 24267226
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome.
Ozaki Y; Tanaka A; Nishiguchi T; Komukai K; Taruya A; Satogami K; Kashiwagi M; Kuroi A; Matsuo Y; Ino Y; Kitabata H; Kubo T; Hozumi T; Akasaka T
PLoS One; 2018; 13(7):e0200383. PubMed ID: 29995934
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin therapy on non-calcified coronary plaque assessed by 64-slice computed tomography.
Kitagawa T; Yamamoto H; Horiguchi J; Ohashi N; Kunita E; Utsunomiya H; Kihara Y
Int J Cardiol; 2011 Jul; 150(2):146-50. PubMed ID: 20542581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
